Kobayashi, H.; Matsubara, S.; Yoshimoto, C.; Shigetomi, H.; Imanaka, S.
Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia. Biomedicines 2023, 11, 1237.
https://doi.org/10.3390/biomedicines11051237
AMA Style
Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S.
Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia. Biomedicines. 2023; 11(5):1237.
https://doi.org/10.3390/biomedicines11051237
Chicago/Turabian Style
Kobayashi, Hiroshi, Sho Matsubara, Chiharu Yoshimoto, Hiroshi Shigetomi, and Shogo Imanaka.
2023. "Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia" Biomedicines 11, no. 5: 1237.
https://doi.org/10.3390/biomedicines11051237
APA Style
Kobayashi, H., Matsubara, S., Yoshimoto, C., Shigetomi, H., & Imanaka, S.
(2023). Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia. Biomedicines, 11(5), 1237.
https://doi.org/10.3390/biomedicines11051237